What does Farydak treat?

Farydak (Panobinostat Lactate) may be used to treat multiple myeloma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Farydak?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Farydak. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Farydak is marketed by Secura. You can see Secura's full profile, rating, and other products on pharmaranks.

Is Farydak a brand-name or generic drug?

Farydak is a brand-name product with the active ingredient Panobinostat Lactate.

Is Farydak available over the counter?

No. Farydak is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Farydak come in?

Farydak is currently marketed as capsule, per the FDA's National Drug Code Directory.

Is Farydak FDA-registered?

Farydak is on record with the U.S. FDA under application number NDA205353. You can verify this on its official FDA label.

farydak

Farydak (Panobinostat Lactate) is a medication used to treat Multiple Myeloma.

Panobinostat Lactate · by Secura

Not yet rated· sourced from the FDA label

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Verified againstopenFDANIH DailyMedRxClass

See alternatives →

Key facts

Active ingredient: Panobinostat Lactate
Form: Capsule
Strength: Panobinostat Lactate EQ 10MG Base · Panobinostat Lactate EQ 15MG Base · Panobinostat Lactate EQ 20MG Base
Type: Prescription (Rx)
Brand or generic: Brand-name
May treat: multiple myeloma
Manufacturer: Secura
FDA application: NDA205353
Availability: Discontinued (per FDA)

May treat (source: NIH RxClass)

multiple myeloma

Dosage forms

Capsule

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

What does Farydak treat?: Farydak (Panobinostat Lactate) may be used to treat multiple myeloma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
Is there a coupon or discount for Farydak?: pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Farydak. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Who makes Farydak?: Farydak is marketed by Secura. You can see Secura's full profile, rating, and other products on pharmaranks.
Is Farydak a brand-name or generic drug?: Farydak is a brand-name product with the active ingredient Panobinostat Lactate.
Is Farydak available over the counter?: No. Farydak is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
What forms does Farydak come in?: Farydak is currently marketed as capsule, per the FDA's National Drug Code Directory.
Is Farydak FDA-registered?: Farydak is on record with the U.S. FDA under application number NDA205353. You can verify this on its official FDA label.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

What people report to the FDA about PANOBINOSTAT LACTATE

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 7 reports naming PANOBINOSTAT LACTATE — the active ingredient in Farydak, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

electrocardiogram qt prolonged3 reports
plasma cell myeloma3 reports
adverse event2 reports
haemoglobin decreased2 reports
leukoencephalopathy2 reports
fatigue1 reports
intentional product use issue1 reports

Read these as a signal, not a rate. A report does not mean PANOBINOSTAT LACTATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved September 25, 2026.